the association of the british pharmaceutical industry
the association of the british pharmaceutical industry Company Information
Company Number
09826787
Website
www.abpi.org.ukRegistered Address
2nd floor, goldings house, hay's galleria, london, SE1 2HB
Industry
Activities of business and employers membership organisations
Telephone
02079303477
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
-0%
the association of the british pharmaceutical industry Estimated Valuation
Pomanda estimates the enterprise value of THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY at £21.9m based on a Turnover of £22.6m and 0.97x industry multiple (adjusted for size and gross margin).
the association of the british pharmaceutical industry Estimated Valuation
Pomanda estimates the enterprise value of THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY at £26.4m based on an EBITDA of £1.8m and a 14.91x industry multiple (adjusted for size and gross margin).
the association of the british pharmaceutical industry Estimated Valuation
Pomanda estimates the enterprise value of THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY at £23.1m based on Net Assets of £8.6m and 2.7x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Association Of The British Pharmaceutical Industry AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
The Association Of The British Pharmaceutical Industry Overview
The Association Of The British Pharmaceutical Industry is a live company located in london, SE1 2HB with a Companies House number of 09826787. It operates in the activities of business and employers membership organizations sector, SIC Code 94110. Founded in October 2015, it's largest shareholder is unknown. The Association Of The British Pharmaceutical Industry is a young, large sized company, Pomanda has estimated its turnover at £22.6m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Association Of The British Pharmaceutical Industry Health Check
Pomanda's financial health check has awarded The Association Of The British Pharmaceutical Industry a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 1 areas for improvement. Company Health Check FAQs
6 Strong
3 Regular
1 Weak
Size
annual sales of £22.6m, make it larger than the average company (£1.3m)
£22.6m - The Association Of The British Pharmaceutical Industry
£1.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a faster rate (0.6%)
4% - The Association Of The British Pharmaceutical Industry
0.6% - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (74.5%)
100% - The Association Of The British Pharmaceutical Industry
74.5% - Industry AVG
Profitability
an operating margin of 6.9% make it more profitable than the average company (2.6%)
6.9% - The Association Of The British Pharmaceutical Industry
2.6% - Industry AVG
Employees
with 96 employees, this is above the industry average (13)
96 - The Association Of The British Pharmaceutical Industry
13 - Industry AVG
Pay Structure
on an average salary of £111.8k, the company has a higher pay structure (£49.2k)
£111.8k - The Association Of The British Pharmaceutical Industry
£49.2k - Industry AVG
Efficiency
resulting in sales per employee of £235.4k, this is more efficient (£113k)
£235.4k - The Association Of The British Pharmaceutical Industry
£113k - Industry AVG
Debtor Days
it gets paid by customers after 30 days, this is near the average (35 days)
30 days - The Association Of The British Pharmaceutical Industry
35 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - The Association Of The British Pharmaceutical Industry
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - The Association Of The British Pharmaceutical Industry
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 68 weeks, this is average cash available to meet short term requirements (71 weeks)
68 weeks - The Association Of The British Pharmaceutical Industry
71 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 43.6%, this is a similar level of debt than the average (43.5%)
43.6% - The Association Of The British Pharmaceutical Industry
43.5% - Industry AVG
the association of the british pharmaceutical industry Credit Report and Business Information
The Association Of The British Pharmaceutical Industry Competitor Analysis
Perform a competitor analysis for the association of the british pharmaceutical industry by selecting its closest rivals and benchmarking them against 12 key performance metrics.
the association of the british pharmaceutical industry Ownership
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY group structure
The Association Of The British Pharmaceutical Industry has no subsidiary companies.
Ultimate parent company
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY
09826787
the association of the british pharmaceutical industry directors
The Association Of The British Pharmaceutical Industry currently has 19 directors. The longest serving directors include Mr Richard Erwin (Sep 2016) and Mr Lars Bruening (May 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Richard Erwin | United Kingdom | 57 years | Sep 2016 | - | Director |
| Mr Lars Bruening | England | 61 years | May 2018 | - | Director |
| Mr Thomas Keith-Roach | England | 52 years | Mar 2020 | - | Director |
| Mr Neale Belson | England | 61 years | Mar 2020 | - | Director |
| Mr Todd Manning | United Kingdom | 53 years | May 2020 | - | Director |
| Mr Russell Abberley | 49 years | Jun 2020 | - | Director | |
| Doinita Ionescu | England | 57 years | May 2021 | - | Director |
| Susan Rienow | England | 44 years | May 2021 | - | Director |
| Ms Jessamy Baird | England | 53 years | Aug 2021 | - | Director |
| Mr Benjamin Lucas | England | 49 years | Apr 2022 | - | Director |
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY financials
The Association Of The British Pharmaceutical Industry's latest turnover from December 2022 is £22.6 million and the company has net assets of £8.6 million. According to their latest financial statements, The Association Of The British Pharmaceutical Industry has 96 employees and maintains cash reserves of £8.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 22,599,134 | 20,829,215 | 18,898,560 | 19,920,999 | 18,068,936 | 17,976,109 | 15,711,270 | 15,532,014 |
| Other Income Or Grants | 0 | 0 | 0 | |||||
| Cost Of Sales | 0 | 0 | 0 | |||||
| Gross Profit | 22,599,134 | 20,829,215 | 18,898,560 | |||||
| Admin Expenses | 21,037,940 | 19,087,932 | 17,654,489 | |||||
| Operating Profit | 1,561,194 | 1,741,283 | 1,244,071 | 1,823,274 | -462,516 | 532,774 | -1,014,908 | -670,069 |
| Interest Payable | 665 | 995 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 75,460 | 13,380 | 18,056 | 39,497 | 35,734 | 7,583 | 31,584 | 51,454 |
| Pre-Tax Profit | 1,635,989 | 1,753,668 | 1,262,127 | 1,862,771 | -426,782 | 540,357 | -983,324 | -618,615 |
| Tax | -248,811 | -245,801 | -253,969 | -309,548 | 89,743 | -104,616 | 253,322 | 89,733 |
| Profit After Tax | 1,387,178 | 1,507,867 | 1,008,158 | 1,553,223 | -337,039 | 435,741 | -730,002 | -528,882 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 1,387,178 | 1,507,867 | 1,008,158 | 1,553,223 | -337,039 | 435,741 | -730,002 | -528,882 |
| Employee Costs | 10,734,359 | 9,937,477 | 9,418,702 | 9,241,605 | 9,363,336 | 8,341,214 | 8,286,075 | 7,952,780 |
| Number Of Employees | 96 | 88 | 86 | 87 | 83 | 81 | 81 | 81 |
| EBITDA* | 1,771,802 | 1,929,979 | 1,476,237 | 1,996,853 | -290,391 | 853,604 | -697,330 | -670,069 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,683,012 | 544,539 | 308,387 | 466,391 | 494,566 | 477,074 | 670,567 | 979,613 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 396,451 | 475,801 | 475,801 | 475,801 | 480,533 | 485,265 | 494,728 | 326,820 |
| Total Fixed Assets | 2,079,463 | 1,020,340 | 784,188 | 942,192 | 975,099 | 962,339 | 1,165,295 | 1,306,433 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 1,884,324 | 2,765,898 | 1,376,390 | 1,689,031 | 1,656,973 | 1,927,846 | 1,579,603 | 2,186,219 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 2,856,609 | 1,407,589 | 1,909,237 | 1,993,431 | 1,374,724 | 908,927 | 872,277 | 667,306 |
| Cash | 8,337,414 | 7,595,594 | 7,603,134 | 4,631,191 | 5,019,017 | 5,973,779 | 4,641,024 | 6,423,590 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 13,078,347 | 11,769,081 | 10,888,761 | 8,313,653 | 8,050,714 | 8,810,552 | 7,092,904 | 9,277,115 |
| total assets | 15,157,810 | 12,789,421 | 11,672,949 | 9,255,845 | 9,025,813 | 9,772,891 | 8,258,199 | 10,583,548 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,362,252 | 723,737 | 442,756 | 550,502 | 853,207 | 1,178,715 | 899,087 | 828,586 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 4,959,674 | 4,396,718 | 5,113,428 | 3,639,736 | 4,703,222 | 4,830,753 | 4,074,430 | 5,756,009 |
| total current liabilities | 6,321,926 | 5,120,455 | 5,556,184 | 4,190,238 | 5,556,429 | 6,009,468 | 4,973,517 | 6,584,595 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 284,491 | 504,751 | 460,417 | 417,417 | 374,417 | 331,417 | 288,417 | 272,686 |
| total long term liabilities | 284,491 | 504,751 | 460,417 | 417,417 | 374,417 | 331,417 | 288,417 | 272,686 |
| total liabilities | 6,606,417 | 5,625,206 | 6,016,601 | 4,607,655 | 5,930,846 | 6,340,885 | 5,261,934 | 6,857,281 |
| net assets | 8,551,393 | 7,164,215 | 5,656,348 | 4,648,190 | 3,094,967 | 3,432,006 | 2,996,265 | 3,726,267 |
| total shareholders funds | 8,551,393 | 7,164,215 | 5,656,348 | 4,648,190 | 3,094,967 | 3,432,006 | 2,996,265 | 3,726,267 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | 1,561,194 | 1,741,283 | 1,244,071 | 1,823,274 | -462,516 | 532,774 | -1,014,908 | -670,069 |
| Depreciation | 210,608 | 188,696 | 232,166 | 173,579 | 172,125 | 320,830 | 317,578 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -248,811 | -245,801 | -253,969 | -309,548 | 89,743 | -104,616 | 253,322 | 89,733 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 488,096 | 887,860 | -396,835 | 646,033 | 190,192 | 375,430 | -233,737 | 3,180,345 |
| Creditors | 638,515 | 280,981 | -107,746 | -302,705 | -325,508 | 279,628 | 70,501 | 828,586 |
| Accruals and Deferred Income | 562,956 | -716,710 | 1,473,692 | -1,063,486 | -127,531 | 756,323 | -1,681,579 | 5,756,009 |
| Deferred Taxes & Provisions | -220,260 | 44,334 | 43,000 | 43,000 | 43,000 | 43,000 | 15,731 | 272,686 |
| Cash flow from operations | 2,016,106 | 404,923 | 3,028,049 | -281,919 | -800,879 | 1,452,509 | -1,805,618 | 3,096,600 |
| Investing Activities | ||||||||
| capital expenditure | 0 | 0 | 0 | 0 | -196,755 | -152,025 | -23,094 | 0 |
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | 0 | 0 | 0 | -196,755 | -152,025 | -23,094 | 0 |
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | 74,795 | 12,385 | 18,056 | 39,497 | 35,734 | 7,583 | 31,584 | 51,454 |
| cash flow from financing | 74,795 | 12,385 | 18,056 | 39,497 | 35,734 | 7,583 | 31,584 | 4,306,603 |
| cash and cash equivalents | ||||||||
| cash | 741,820 | -7,540 | 2,971,943 | -387,826 | -954,762 | 1,332,755 | -1,782,566 | 6,423,590 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 741,820 | -7,540 | 2,971,943 | -387,826 | -954,762 | 1,332,755 | -1,782,566 | 6,423,590 |
P&L
December 2022turnover
22.6m
+8%
operating profit
1.6m
-10%
gross margin
100%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
8.6m
+0.19%
total assets
15.2m
+0.19%
cash
8.3m
+0.1%
net assets
Total assets minus all liabilities
the association of the british pharmaceutical industry company details
company number
09826787
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
94110 - Activities of business and employers membership organisations
incorporation date
October 2015
age
9
accounts
Group
ultimate parent company
previous names
N/A
incorporated
UK
address
2nd floor, goldings house, hay's galleria, london, SE1 2HB
last accounts submitted
December 2022
the association of the british pharmaceutical industry Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the association of the british pharmaceutical industry.
the association of the british pharmaceutical industry Companies House Filings - See Documents
| date | description | view/download |
|---|
